Intuitive Surgical, Inc. vs RLX Technology Inc — how do they compare? Intuitive Surgical, Inc. trades at $401.05 (market cap $141.75B), while RLX Technology Inc trades at $2.02 (market cap $2.42B). The key difference: Intuitive Surgical, Inc. is far larger — about 58.6× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.05% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | RLX | |
|---|---|---|
Market Cap | $141.75B | $2.42B |
Sector | Health | Technology |
52-Week High | $592.85 | $2.73 |
52-Week Low | $332.02 | $1.79 |
Enterprise Value | $136.53B | $1.04B |
Dividend Yield | — | 5.05% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $401.46, up 2.05% today, with strong quarterly earnings beats and bullish analyst consensus. The stock shows robust revenue growth, expanding margins, and solid cash flow, supported by the da Vinci 5 system adoption. Technical indicators are mixed, with RSI signaling overbought conditions but moving averages bullish.
Outlook remains positive due to durable demand and innovation, though high valuation and competition pose risks. Upside to the $518.10 consensus target offers potential, but investors should weigh premium multiples against growth sustainability.
RLX Technology trades at $2.02, up 1.0% with bearish technical signals despite recent earnings misses. The company maintains strong profitability with 22.47% net margins and international expansion driving revenue growth from $3.62B to $4.4B. Cash flow trends show operational strength but negative net cash flow. Analyst coverage remains limited with a single hold rating.
RLX faces execution risks from international integration while trading at reasonable valuations (P/E 17.96). The upcoming Q2 2026 earnings on August 14 will be crucial for validating growth trajectory amid competitive and regulatory pressures in the global e-vapor market.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →